Did You Know?

Editor’s Picks

Latest News

BioCorRx Submits Fast Track Application to FDA for BICX104, an Implantable Biodegradable Naltrexone Pellet for The Treatment of Opioid Use Disorder

ANAHEIM, CA, July 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and...

National Evaluation System for health Technology Coordinating Center (NESTcc) Releases a Request for Proposal Relating to its Medical Device Active Surveillance Program

NESTcc’s Active Surveillance Program for Medical Devices takes the next stepARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology Coordinating...

error: Content is protected !!